loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 206099 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 CURRAX (1)

filter

01 POWDER;NASAL (1)

filter

01 RX (1)

filter

01 ONZETRA XSAIL (1)

filter

01 Yes (1)

URL Supplier Web Content
POWDER; NASAL
EQ 11MG BASE
2016-01-27
206099
ONZETRA XSAIL
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 206099

Looking for FDA Orange Book APPLICATION 206099 1

19

Currax, based in U.S.A, is a pharmaceutical company.

One of their notable products is SUMATRIPTAN SUCCINATE, with a corresponding application number 206099.

Regulatory Information RX

With a dosage strength EQ 11MG BASE

Dosage Form Route POWDER; NASAL

Reference Listed Drug Yes

Approved since 2016-01-27

Post Enquiry
POST ENQUIRY